✦ LIBER ✦

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma

✍ Scribed by Jacob D Bitran; Leonard Klein; Doreen Link; Jane Kosirog-Glowacki; Cynthia Stewart; David Raack; Pat Sheahan; Josephine Lisowski; Josie Rowen

Book ID: 117727910
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 102 KB
Volume: 9
Category: Article
ISSN: 1083-8791
DOI: 10.1016/s1083-8791(03)00099-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The non-relapse mortality rate for patie

The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls

✍ Brian T. Hill; Lisa Rybicki; Brian J. Bolwell; Stephen Smith; Robert Dean; Matt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Early versus late intensification for pa

Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group

✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views